Biologic therapies associated with development of palmoplantar pustulosis and palmoplantar pustular psoriasis: a systematic review-Reference-Cited by-同舟云学术

Biologic therapies associated with development of palmoplantar pustulosis and palmoplantar pustular psoriasis: a systematic review

Published:2022-02-06 Issue:1 Volume:62 Page:12-21
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatology

Author:

Lu Justin D.¹,Lytvyn Yuliya²,Mufti Asfandyar³,Zaaroura Hiba³,Sachdeva Muskaan²^ORCID,Kwan Sarah³,Abduelmula Abrahim⁴,Kim Patrick¹^ORCID,Yeung Jensen²³⁵⁶⁷

Affiliation:

1. Faculty of Medicine Michael G. DeGroote School of Medicine Hamilton Ontario Canada

2. Faculty of Medicine University of Toronto Toronto Ontario Canada

3. Department of Dermatology University of Toronto Toronto Ontario Canada

4. Faculty of Medicine Schulich School of Medicine and Dentistry London Ontario Canada

5. Sunnybrook Health Sciences Centre Toronto Ontario Canada

6. Women's College Hospital Toronto Ontario Canada

7. Probity Medical Research Inc. Waterloo Ontario Canada

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.16064

Reference70 articles.

1. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study

2. Palmoplantar psoriasis: A phenotypical and clinical review with introduction of a new quality-of-life assessment tool

3. Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathway

4. Pustulosis palmoplantaris is a disease distinct from psoriasis

5. Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Doctora: «¡La podóloga ya no sabe qué hacer!»;Actualización en Medicina de Familia;2024-01-01

2. Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies;Psoriasis: Targets and Therapy;2023-09

3. Adalimumab-induced palmoplantar pustulosis in a patient with inflammatory bowel disease;CosmoDerma;2022-07-25